Every woman who considers implants in Dubai asks me some version of the same question: are they safe? It deserves a better answer than yes. Safety is not a property the device possesses. It is divided, unevenly, between what the implant carries into the operating room and what happens to it once it is there.
I explain this division to every augmentation patient in Dubai. The shell surface arrives with the implant, and with it the only established risk factor for a rare lymphoma. But capsular contracture — the commonest problem by far — is substantially decided in the hour the implant spends being inserted. That division is the honest structure of this subject, and it is why I would rather tell you what I control than assure you that everything is fine.
Key takeaways: safety, divided honestly
- The shell surface is the only established risk factor for BIA-ALCL.
- No confirmed case has arisen in a woman with smooth implants only.
- But 30% of reports omit the surface, so this is not proof of zero.
- Capsular contracture is largely a bacterial film, not bad luck.
- A study of 55,279 women found no increased systemic disease.
- A study of 99,993 women found higher autoimmune rates. Both are true.
A note on scope: this article is about the risks themselves. How long implants last, when a rupture matters, and whether you should exchange them is the subject of my article on why there is no ten-year rule. What removal can honestly promise, and the capsule questions that follow, are covered in my article on breast implant removal.
The lymphoma, stated precisely
Breast implant-associated anaplastic large cell lymphoma is a cancer of the immune system rather than of the breast. It is uncommon, and when found early it is usually curable. It typically presents late — a swelling or fluid collection appearing years after surgery, on average eight to ten.
Its association with textured implant surfaces is the clearest thing we know about it. Every reported case in which a complete implant history was available involved a textured device at some point. I therefore use smooth-shell implants for primary augmentation, which removes the only device risk factor that has ever been established.
Now the sentence that most surgeons omit. My own society states that there are no confirmed cases involving only a smooth implant — and immediately adds that the medical records of many women diagnosed did not specify whether their implants were textured. The joint advisory notes that three in ten cases reported to the regulator do not record the surface at all.
No published case report of the disease in a smooth-only patient exists anywhere in the world, despite thousands of surgeons watching for one. That is genuinely reassuring. It is not the same as elimination, and I will not tell you it is. A surgeon should not promise more certainty about a cancer than his own society will.
How implant safety divides between what the device carries and what the surgeon controls, by Dr. Nazmi Baycin, Dubai.
The film of bacteria nobody mentions
Capsular contracture is the commonest complication of breast augmentation, and it is widely presented to patients as misfortune. Every implant is surrounded by a capsule of scar; in a minority that capsule thickens, tightens, and squeezes the implant into a hard, distorted, sometimes painful shape.
The leading explanation is not misfortune. It is a biofilm — a population of bacteria too small to cause any infection you would notice, settling on the implant surface at the moment of insertion and provoking a chronic inflammatory response. The body answers that low-grade irritation with scar. This reframes the entire problem: most of what prevents contracture is a matter of never letting the bacteria arrive.
What I actually do about it
My protocol is unglamorous and it is the substance of the operation. Nothing here is proprietary; it is simply done in every augmentation I perform in Dubai, without exception.
- Nipple shields throughout, because the ducts harbor bacteria and open onto the skin.
- Antibacterial irrigation of the pocket before the implant enters it.
- An insertion funnel, so that no glove and no skin edge ever touches the device.
- Fresh gloves and clean instruments at the moment of insertion.
- A dry pocket, because blood is a culture medium and a hematoma is an invitation.
- Careful dissection rather than blunt tearing, and the shortest exposure the work allows.
Notice how much of this is discipline rather than skill. It is the reason I regard contracture rates as a statement about a surgeon’s habits rather than about a patient’s misfortune. The operation itself is described on my page about breast augmentation in Dubai.
| Risk | What patients are told | What the evidence shows | Who controls it |
|---|---|---|---|
| BIA-ALCL | Smooth eliminates it | No confirmed smooth-only case | The device, largely |
| Capsular contracture | Bad luck | Bacterial film on the shell | The surgeon, largely |
| Systemic illness | Fully disproven | Two large studies disagree | Neither, honestly |
| Hematoma | An uncommon event | A culture medium for bacteria | The surgeon, entirely |
Systemic illness: both findings belong in the room
Here I must resist the temptation to reassure you by selecting my evidence. A study following more than 55,000 women for five to eight years found no increased risk of connective tissue disease, neurological disease, cancer, or suicide compared with national norms or with saline implants. That is a large, careful, reassuring dataset, and it is the one my profession quotes.
It is not the only one. An analysis of regulator-mandated studies covering 99,993 patients reported higher rates of Sjogren syndrome, scleroderma, and rheumatoid arthritis among women with silicone implants than in the general population. That finding has limitations of its own, and it does not establish causation. But it exists, and a page calling itself a comprehensive review has no business omitting it.
So the honest summary is this: large studies have not demonstrated that implants cause systemic disease, the association remains contested rather than closed, and a surgeon who quotes you only the reassuring study is not informing you but selling to you. Women who report systemic symptoms are describing something real, whatever its mechanism, and I address what removal can and cannot do for them elsewhere.
What I tell you before you consent
A woman cannot consent to a risk she has not been told about, and consent obtained by reassurance is not consent at all. So my conversation covers the lymphoma and its association with texture, the contracture and my protocol against it, the systemic question and the fact that the literature disagrees with itself, and the plain statement that implants are medical devices rather than permanent parts of the body.
None of that is designed to frighten. Most women with implants have no trouble at all. But an informed woman is a safer patient, because she knows what a late swelling means, why a hard breast is worth reporting, and that she is entitled to ask her surgeon what he does in the minutes when the implant is out of its box.
The question worth asking
If you are choosing a surgeon, ask him about biofilm. Ask what he irrigates the pocket with, whether he uses a funnel, whether he changes gloves before the implant is touched. A surgeon who answers those questions fluently has thought about the risk you are most likely to actually encounter.
And ask him what he cannot control, and listen for whether he admits there is anything. Safety in this field is a division of responsibility between a device and a discipline, and the honest account of it is the one that names both. That is the standard I hold at my cosmetic surgery clinic in Dubai.
FAQs about breast implant safety in Dubai
-
Do smooth implants eliminate the risk of BIA-ALCL?
They remove the only device risk factor ever established, and I use them for primary augmentation for exactly that reason. But I will not tell you they eliminate the risk, because my own society does not say so. There are no confirmed cases involving only a smooth implant, and despite thousands of surgeons worldwide watching for one, no published case report exists. That is genuinely reassuring. So the caveat matters: three in ten cases reported to the regulator do not record the implant surface at all. No confirmed case is not the same as none, and you deserve the precise sentence rather than the comfortable one.
-
What is BIA-ALCL, exactly?
It is a cancer of the immune system, not a cancer of the breast. It is uncommon, and when it is found early it is usually curable. It tends to present late, on average eight to ten years after surgery, as a swelling or a collection of fluid around the implant rather than as a lump you would find yourself. So the practical lesson is not fear but vigilance. A breast that swells years after an uneventful augmentation should be examined and scanned, and that is a sentence I want you to remember.
-
Why does capsular contracture happen?
Not, in most cases, by bad luck. The leading explanation is a biofilm: a population of bacteria too small to cause any infection you would notice, settling on the implant surface at the moment it is inserted. The body answers that low-grade irritation with scar, and the capsule thickens, tightens, and distorts the breast. So contracture is largely a problem of contamination rather than misfortune. That reframing is the whole reason my sterile protocol looks the way it does.
-
What do you do to prevent contracture?
Nipple shields throughout, because the ducts harbor bacteria and open onto the skin. Antibacterial irrigation of the pocket before the implant enters it. An insertion funnel, so that no glove and no skin edge ever touches the device. Fresh gloves and clean instruments at the moment of insertion. A dry pocket, because blood is a culture medium. Careful dissection rather than blunt tearing. So almost all of it is discipline rather than skill. I regard contracture rates as a statement about a surgeon’s habits rather than about a patient’s luck.
-
Do implants cause autoimmune disease?
The literature disagrees with itself, and I think you should hear both halves. A study following more than 55,000 women for five to eight years found no increased risk of connective tissue disease, neurological disease, cancer or suicide. An analysis of regulator-mandated studies covering nearly 100,000 patients reported higher rates of Sjogren’s syndrome, scleroderma and rheumatoid arthritis than in the general population. So large studies have not demonstrated that implants cause systemic disease, and the question is contested rather than closed. A surgeon who quotes you only the reassuring study is selling rather than informing.
-
Are saline implants safer than silicone?
The large comparative study I rely on found no increased risk of systemic disease with silicone implants when measured against saline implants or against national norms. Where they differ is in how a rupture behaves. A saline implant deflates visibly; a silicone one may fail silently, which is why imaging is recommended for silicone. So the choice between them is usually about feel, about how a failure would announce itself, and about your own preference, rather than about systemic safety.
-
Should I be worried if my breast becomes swollen years later?
You should have it examined, without panic and without delay. A late swelling or fluid collection is the characteristic presentation of BIA-ALCL, appearing on average eight to ten years after surgery. It is far more likely to be something benign. But the reason this cancer is usually curable is that it is caught early, and it is caught early because women report the swelling. So the answer is not to worry but to act. Any breast that changes size or hardness years after an uneventful operation deserves an examination and a scan.
-
What should I ask my surgeon about safety?
Ask him about biofilm. Ask what he irrigates the pocket with, whether he uses an insertion funnel, whether he changes gloves before the implant is touched. A surgeon who answers those fluently has thought hard about the complication you are most likely to actually meet, which is contracture rather than lymphoma. So then ask him what he cannot control, and listen for whether he concedes anything at all. Safety here is divided between a device and a discipline, and the honest account names both.
GET APPOINTMENT
Get ready to look and feel best… You deserve…
